Document is current
Any future updates will be listed below
-
Authors
Taxer, Kathrin https://orcid.org/0009-0002-0077-1385
Wimmer, Katharina https://orcid.org/0000-0002-0732-7538
Wadt, Karin
Schnaiter, Simon https://orcid.org/0009-0009-5213-6237
Rudnik, Sabine https://orcid.org/0000-0001-8332-0672
Zschocke, Johannes https://orcid.org/0000-0002-0046-8274
,
Bajalica-Lagercrantz, Svetlana
van de Beek, Irma
Brems, Hilde
de Putter, Robin
Foretova, Lenka
Haanpää, Maria K.
Hes, Frederik J.
Kahre, Tiina
Klink, Barbara
Krajc, Mateja
Macchiaiolo, Marina
Macek, Milan
Mensenkamp, Arjen
Percesepe, Antonio
Reis, André
Renieri, Alessandra
Ripperger, Tim https://orcid.org/0000-0001-6470-8612
Bravo, María Constanza Roa
Teixeira, Manuel R.
Tesner, Pavel
Theis, Philippe
van Overeem Hansen, Thomas
Vaz, Fatima
Vetti, Hildegunn Høberg
Schwaninger, Gunda https://orcid.org/0000-0002-2120-848X
- License Information
-
More Information
Article History
Received: 7 August 2025
Revised: 12 January 2026
Accepted: 4 February 2026
First Online: 3 March 2026
Competing interests
: KW: Honorarium for lecture regarding breast cancer from Seagen, Thomas v. O. Hansen has received lecture fees from AstraZeneca/MSD; The other authors did not declare a competing of interest.
: All data presented were retrieved from a voluntary survey. Participants were made aware that answers would be used for publication on the first page of the survey. The option for fully anonymised participation was given to all participants. The research did not qualify for submission to an IRB or research ethics committee at the Medical University of Innsbruck, as only experts professionals received the survey.
